Browsing Tag: Emcure Zuventus acquisition

Shares of Emcure Pharmaceuticals Ltd have rallied 53% over the last six months, signaling strong momentum in the broader pharma space. However, the stock still remains down 1.84% year-to-date (YTD) de...